Prelude Therapeutics Stock (NASDAQ: PRLD) stock price, news, charts, stock research, profile.
Open | $2.56 |
Close | - |
Volume / Avg. | 54.04K / 254.99K |
Day Range | $2.36 - $2.56 |
52 Wk Range | 1.66 - 6.80 |
Market Cap | $133.16M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 28 |
Short Interest | 14.04% |
Days to Cover | 10.91 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Prelude Therapeutics (NASDAQ:PRLD) through any online brokerage.
Other companies in Prelude Therapeutics’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Adverum Biotechnologies (NASDAQ:ADVM), Inovio Pharmaceuticals (NASDAQ:INO), Adicet Bio (NASDAQ:ACET) and Agenus (NASDAQ:AGEN).
Prelude Therapeutics has a consensus price target of $6.00.
The stock price for Prelude Therapeutics (NASDAQ: PRLD) is $2.42 last updated September 23, 2024 at 11:51 AM EDT.
There are no upcoming dividends for Prelude Therapeutics.
Prelude Therapeutics’s Q3 earnings are confirmed for Wednesday, October 30, 2024.
There is no upcoming split for Prelude Therapeutics.
Prelude Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.